Vimarsana
Biggest News Aggregation in the World

Page 10 - Framework Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Framework Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Framework Programme Today - Breaking & Trending Today

Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquac - Vimarsana News

Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquac

Aquaculture Vaccine MarketThe global Aquaculture Vaccines Market is worth US$ 406 Million as of now and is expected to reach US$ 913.6 Million by the year 2033 at a CAGR of 8.5% between 2023 and 2033.Surge in aquaculture is the factor majorly driving the aquaculture vaccines market. There is an ever-increasing deman...

EXCLUSIVE: Here's what the member states have in mind for FP10 | Science - Vimarsana News

EXCLUSIVE: Here's what the member states have in mind for FP10 | Science

A special member state task force set up to help shape framework programme 10 (FP10), has compiled the first draft of an opinion that is due by June next year. The documents, seen by Science|Business, set out in broad strokes the member states’ ideas for FP10, including a call for the EU to be a global research and innovation powerhouse by 2034.

Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquac - Vimarsana News

Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquac

The global Aquaculture Vaccines Market is worth US$ 406 Million as of now and is expected to reach US$ 913.6 Million by the year 2033 at a CAGR of 8.5% between 2023 and 2033.Surge in aquaculture is the factor majorly driving the aquaculture vaccines market. There is an ever-increasing demand for canned fish products...

Can a Drug for Overactive Bladder Prevent Heart Failure? - Vimarsana News

Can a Drug for Overactive Bladder Prevent Heart Failure?

Repurposing mirabegron, a drug used to treat overactive bladder disease, did not significantly change left ventricular mass index or diastolic function in pre–heart failure structural heart disease.

Fine print of Horizon Europe deal ties UK into the next framework programme - Vimarsana News

Fine print of Horizon Europe deal ties UK into the next framework programme

The deal under which the UK is to associate to Horizon Europe contains a potential financial incentive for the country to continue into next Framework Programme 10 (FP10) research programme, according to the fine print of the agreement. The agreement announced on 7 September says the UK will be able to claw back money if it pays 16% more into the scheme than it gets out, a term that gave the UK government enough financial security to agree a deal.